Suspended

Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Data Collection

Who is being recruted

Anemia+1

+ Hematologic Diseases

+ Hemic and Lymphatic Diseases

Over 18 Years
+7 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Phase 3
Interventional
Study Start: February 2004
See protocol details

Summary

Principal SponsorJohnson & Johnson Pharmaceutical Research & Development, L.L.C.
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: February 1, 2004

Actual date on which the first participant was enrolled.

The purpose of this study is to examine the effectiveness of epoetin alfa in treating anemia in patients who have cancer or who no longer have any signs of the cancer, but remain anemic as a result of their treatment.

Official TitleTreatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy
NCT00083434
Principal SponsorJohnson & Johnson Pharmaceutical Research & Development, L.L.C.
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

AnemiaHematologic DiseasesHemic and Lymphatic DiseasesNeoplasms

Criteria

5 inclusion criteria required to participate
ECOG 0-2
18 years of age or older
Body weight >/= 99lbs
Anemia results from cancer, chemotherapy, radiotherapy or an association with hormonal therapy or immunotherapy
Show More Criteria
2 exclusion criteria prevent from participating
History of or concurrent second malignancy
Evidence of primary or metastatic malignancy involving the Central Nervous System

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 6 locations

Suspended

Advanced Urology Medical Center

Anaheim, United StatesOpen Advanced Urology Medical Center in Google Maps
Suspended

Shapiro, Stafford & Yee

Arcadia, United States
Suspended

California Cancer Center

Fresno, United States
Suspended

Tukoi Research

North Miami, United States
Suspended6 Study Centers